ACTL7B
gene geneOn this page
Also known as Tact1
Summary
ACTL7B (actin like 7B, HGNC:162) is a protein-coding gene on chromosome 9q31.3, encoding Actin-like protein 7B (Q9Y614).
The protein encoded by this gene is a member of a family of actin-related proteins (ARPs) which share significant amino acid sequence identity to conventional actins. Both actins and ARPs have an actin fold, which is an ATP-binding cleft, as a common feature. The ARPs are involved in diverse cellular processes, including vesicular transport, spindle orientation, nuclear migration and chromatin remodeling. This gene (ACTL7B), and related gene, ACTL7A, are intronless, and are located approximately 4 kb apart in a head-to-head orientation within the familial dysautonomia candidate region on 9q31. Based on mutational analysis of the ACTL7B gene in patients with this disorder, it was concluded that it is unlikely to be involved in the pathogenesis of dysautonomia. Unlike ACTL7A, the ACTL7B gene is expressed predominantly in the testis, however, its exact function is not known.
Source: NCBI Gene 10880 — RefSeq curated summary.
At a glance
- GWAS associations: 9
- Clinical variants (ClinVar): 99 total
- GTEx eGene: eQTL in 1 tissue, sQTL in 0 (q < 0.05)
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.41 (unconstrained)
- MANE Select transcript:
NM_006686 - Notable: 99 clinical variants but no curated precision-oncology (CIViC) evidence yet
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:162 |
| Approved symbol | ACTL7B |
| Name | actin like 7B |
| Location | 9q31.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Tact1 |
| Ensembl gene | ENSG00000148156 |
| Ensembl biotype | protein_coding |
| OMIM | 604304 |
| Entrez | 10880 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
MANE Select: ENST00000374667
ENST00000374667
RefSeq mRNA: 1 — MANE Select: NM_006686
NM_006686
CCDS: CCDS6771
Canonical transcript exons
ENST00000374667 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001464207 | 108854588 | 108855986 |
Expression profiles
Bgee: expression breadth broad, 47 present calls, max score 97.90.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1086 / max 112.7712, expressed in 3 samples.
Highest expression (Bgee): testis, male germ line stem cell (sensu Vertebrata) in testis, adult organism, sperm, male germ cell.
Genetic regulation across tissues (GTEx eQTL / sQTL)
ACTL7B is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 1 tissue and its splicing (sQTL) in 0 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
1 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Testis | eqtl | 3.8e-11 | -0.13 | 9:108856029:T:C |
FANTOM5 promoters
1 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 101859 | 0.1086 | 3 |
Top tissues by expression
showing 100 of 232 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 97.90 | gold quality |
| right testis | UBERON:0004534 | 97.75 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 96.32 | gold quality |
| testis | UBERON:0000473 | 94.73 | gold quality |
| adult organism | UBERON:0007023 | 89.79 | gold quality |
| sperm | CL:0000019 | 85.95 | silver quality |
| male germ cell | CL:0000015 | 85.89 | gold quality |
| heart right ventricle | UBERON:0002080 | 61.35 | gold quality |
| secondary oocyte | CL:0000655 | 58.43 | gold quality |
| ileal mucosa | UBERON:0000331 | 57.67 | silver quality |
| tendon of biceps brachii | UBERON:0008188 | 56.36 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 55.85 | gold quality |
| myocardium | UBERON:0002349 | 55.48 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 55.36 | gold quality |
| vena cava | UBERON:0004087 | 54.65 | gold quality |
| pons | UBERON:0000988 | 53.79 | gold quality |
| oral cavity | UBERON:0000167 | 51.69 | gold quality |
| granulocyte | CL:0000094 | 51.11 | silver quality |
| buccal mucosa cell | CL:0002336 | 51.09 | gold quality |
| bone marrow | UBERON:0002371 | 50.94 | gold quality |
| quadriceps femoris | UBERON:0001377 | 50.80 | gold quality |
| vastus lateralis | UBERON:0001379 | 50.79 | gold quality |
| medial globus pallidus | UBERON:0002477 | 50.24 | gold quality |
| lower lobe of lung | UBERON:0008949 | 50.23 | silver quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 49.30 | gold quality |
| blood vessel layer | UBERON:0004797 | 49.29 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 49.20 | gold quality |
| hair follicle | UBERON:0002073 | 49.18 | gold quality |
| sural nerve | UBERON:0015488 | 48.95 | gold quality |
| olfactory bulb | UBERON:0002264 | 48.92 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 48.89 | gold quality |
| type B pancreatic cell | CL:0000169 | 48.83 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 48.55 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 48.50 | gold quality |
| oviduct epithelium | UBERON:0004804 | 48.45 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 48.24 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 48.20 | gold quality |
| oocyte | CL:0000023 | 48.15 | gold quality |
| upper arm skin | UBERON:0004263 | 48.06 | gold quality |
| cervix epithelium | UBERON:0004801 | 48.04 | gold quality |
| globus pallidus | UBERON:0001875 | 47.99 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 47.92 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 47.88 | gold quality |
| mucosa of urinary bladder | UBERON:0001259 | 47.80 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 47.70 | gold quality |
| thymus | UBERON:0002370 | 47.42 | gold quality |
| nephron tubule | UBERON:0001231 | 47.40 | gold quality |
| kidney epithelium | UBERON:0004819 | 47.20 | gold quality |
| periodontal ligament | UBERON:0008266 | 47.14 | gold quality |
| diaphragm | UBERON:0001103 | 47.05 | gold quality |
| gluteal muscle | UBERON:0002000 | 47.03 | gold quality |
| triceps brachii | UBERON:0001509 | 47.01 | gold quality |
| renal glomerulus | UBERON:0000074 | 46.99 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 46.96 | gold quality |
| deltoid | UBERON:0001476 | 46.17 | gold quality |
| mammalian vulva | UBERON:0000997 | 46.04 | gold quality |
| biceps brachii | UBERON:0001507 | 45.81 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 45.76 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 45.59 | gold quality |
| dorsal motor nucleus of vagus nerve | UBERON:0002870 | 45.35 | gold quality |
| inferior olivary complex | UBERON:0002127 | 45.14 | gold quality |
| muscle tissue | UBERON:0002385 | 45.02 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 44.98 | gold quality |
| amniotic fluid | UBERON:0000173 | 43.93 | gold quality |
| right coronary artery | UBERON:0001625 | 43.82 | gold quality |
| squamous epithelium | UBERON:0006914 | 43.42 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| embryo | UBERON:0000922 | 43.23 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 42.92 | gold quality |
| epithelium of esophagus | UBERON:0001976 | 42.87 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 42.82 | gold quality |
| bronchus | UBERON:0002185 | 42.80 | gold quality |
| body of tongue | UBERON:0011876 | 42.71 | gold quality |
| tibialis anterior | UBERON:0001385 | 42.59 | silver quality |
| bone marrow cell | CL:0002092 | 42.58 | gold quality |
| colonic mucosa | UBERON:0000317 | 42.08 | gold quality |
| cartilage tissue | UBERON:0002418 | 42.04 | gold quality |
| medulla oblongata | UBERON:0001896 | 41.74 | gold quality |
| tongue | UBERON:0001723 | 41.42 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 41.42 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 41.34 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| epithelium of mammary gland | UBERON:0003244 | 41.33 | gold quality |
| ventral tegmental area | UBERON:0002691 | 41.25 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| trachea | UBERON:0003126 | 41.02 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| pancreatic ductal cell | CL:0002079 | 40.84 | silver quality |
| jejunal mucosa | UBERON:0000399 | 40.59 | gold quality |
| blood | UBERON:0000178 | 40.54 | silver quality |
| epithelium of nasopharynx | UBERON:0001951 | 40.45 | gold quality |
| gingival epithelium | UBERON:0001949 | 40.43 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 40.33 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 40.29 | gold quality |
| jejunum | UBERON:0002115 | 40.18 | gold quality |
| cranial nerve II | UBERON:0000941 | 40.12 | silver quality |
| bronchial epithelial cell | CL:0002328 | 40.05 | gold quality |
| mammary duct | UBERON:0001765 | 39.98 | gold quality |
| placenta | UBERON:0001987 | 39.88 | gold quality |
| saphenous vein | UBERON:0007318 | 39.83 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.00 |
HPA expression
RNA tissue specificity: Tissue enriched
5 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM | Protein (IHC) |
|---|---|---|---|
| Testis | tissue | 52.7 | high |
| Nucleus accumbens | tissue | 0.1 | |
| Locus coeruleus | tissue | 0.1 | |
| Hippocampus | tissue | 0.1 | not detected |
| Hippocampal formation | tissue | 0.1 |
Brain sub-regions (HPA Brain Atlas): detected in 98; highest nTPM — Arcuate nucleus (0.2), Area parastriata, temporal (0.2), Lingual gyrus (0.2), Precentral gyrus (0.2), Angular gyrus (0.1).
Regulation
Is transcription factor: no
Functional genomics
gnomAD constraint: pLI 1.89e-07, LOEUF 1.41, missense Z -0.61 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000374667 — one region, missense o/e 1.04.
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Actl7b | ENSMUSG00000070980 |
| rattus_norvegicus | Actl7b | ENSRNOG00000016621 |
Paralogs (26): ACTR6 (ENSG00000075089), ACTB (ENSG00000075624), ACTL6B (ENSG00000077080), ACTR5 (ENSG00000101442), ACTR3C (ENSG00000106526), ACTA2 (ENSG00000107796), ACTR8 (ENSG00000113812), ACTR1B (ENSG00000115073), ACTR3 (ENSG00000115091), ACTL8 (ENSG00000117148), ACTRT1 (ENSG00000123165), ACTR10 (ENSG00000131966), ACTR3B (ENSG00000133627), ACTL6A (ENSG00000136518), ACTR2 (ENSG00000138071), ACTR1A (ENSG00000138107), ACTA1 (ENSG00000143632), ACTC1 (ENSG00000159251), ACTG2 (ENSG00000163017), ACTBL2 (ENSG00000169067), ACTRT2 (ENSG00000169717), ACTL9 (ENSG00000181786), ACTG1 (ENSG00000184009), ACTRT3 (ENSG00000184378), ACTL7A (ENSG00000187003), ACTL10 (ENSG00000288649)
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:1343053) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 21 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| male infertility | 2 |
| abnormal urinary bladder morphology | 1 |
| small testis | 1 |
| abnormal spermiogenesis | 1 |
| asthenozoospermia | 1 |
| oligozoospermia | 1 |
| decreased testis weight | 1 |
| decreased epididymis weight | 1 |
| teratozoospermia | 1 |
| abnormal sperm flagellum morphology | 1 |
| abnormal sperm head morphology | 1 |
| abnormal sperm nucleus morphology | 1 |
| abnormal sperm connecting piece morphology | 1 |
| abnormal sperm midpiece morphology | 1 |
| abnormal sperm mitochondrial sheath morphology | 1 |
| absent sperm mitochondrial sheath | 1 |
| abnormal sperm annulus morphology | 1 |
| abnormal seminiferous tubule epithelium morphology | 1 |
| increased male germ cell apoptosis | 1 |
| decreased sperm progressive motility | 1 |
| abnormal outer dense fiber morphology | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Macaca fascicularis | Q4R6Q3 | 98.6% | Diamond |
| Bos taurus | Q32L91 | 89.0% | Diamond |
| Debaryomyces hansenii CBS767 | Q6BXN0 | 73.9% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| ACTL7A | protein-coding | 10881 |
| ABITRAM | protein-coding | 54942 |
| ELP1 | protein-coding | 8518 |
| CTNNAL1 | protein-coding | 8727 |
Protein
Protein identifiers
Actin-like protein 7B — Q9Y614 (reviewed: Q9Y614)
Alternative names: Actin-like-7-beta
All UniProt accessions (2): A0A140VKC6, Q9Y614
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Cytoplasm. Cytoskeleton.
Tissue specificity. Detected only in the testis and, to a lesser extent, in the prostate.
Similarity. Belongs to the actin family.
RefSeq proteins (1): NP_006677* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004000 | Actin | Family |
| IPR043129 | ATPase_NBD | Homologous_superfamily |
Pfam: PF00022
UniProt features (3 total): chain 1, region of interest 1, modified residue 1
Structure
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y614-F1 | 88.35 | 0.80 |
Human Protein Atlas
Protein class: Predicted intracellular proteins
Protein evidence: Evidence at protein level
Antibody reliability (HPA): IH enhanced
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1)
| Type | Positions |
|---|---|
| Phosphoserine | 6 |
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
MSigDB gene sets: 38 (showing top):
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP, YGACNNYACAR_UNKNOWN, GNF2_CCNA1, GOMF_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON, DODD_NASOPHARYNGEAL_CARCINOMA_DN, GOMF_STRUCTURAL_MOLECULE_ACTIVITY, MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED, MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED, ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN, MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED, MARTENS_TRETINOIN_RESPONSE_UP, GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_DN, GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_DN, GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN, GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_UP
GO Biological Process (1): cytoskeleton organization (GO:0007010)
GO Molecular Function (3): structural molecule activity (GO:0005198), structural constituent of cytoskeleton (GO:0005200), protein binding (GO:0005515)
GO Cellular Component (4): nucleus (GO:0005634), cytoplasm (GO:0005737), actin cytoskeleton (GO:0015629), cytoskeleton (GO:0005856)
GO top-level categories
10 GO namespaces:
| Category | Terms |
|---|---|
| cytoskeleton | 2 |
| organelle organization | 1 |
| molecular_function | 1 |
| structural molecule activity | 1 |
| cytoskeleton organization | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
showing 15 of 1,445 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ACTL7B | CTNNAL1 | Q9UBT7 | 928 |
| ACTL7B | ODF1 | Q14990 | 446 |
| ACTL7B | TEX38 | Q6PEX7 | 440 |
| ACTL7B | A0A1W2PNV4 | A0A1W2PNV4 | 429 |
| ACTL7B | CAPZA3 | Q96KX2 | 405 |
| ACTL7B | ELP1 | O95163 | 365 |
| ACTL7B | ODF4 | Q2M2E3 | 349 |
| ACTL7B | PDHA2 | P29803 | 332 |
| ACTL7B | C6orf118 | Q5T5N4 | 320 |
| ACTL7B | CCDC159 | P0C7I6 | 320 |
| ACTL7B | MEIG1 | Q5JSS6 | 320 |
| ACTL7B | SPATA16 | Q9BXB7 | 315 |
| ACTL7B | CFAP74 | Q9C0B2 | 315 |
| ACTL7B | TEX35 | Q5T0J7 | 313 |
| ACTL7B | CNBD2 | Q96M20 | 310 |
IntAct
Human interaction partners of ACTL7B in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
4 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| CASP6 | physical association | 0.560 | 3 |
| HIP1 | physical association | 0.560 | 3 |
| LAMP2 | physical association | 0.560 | 3 |
| RAN | physical association | 0.560 | 3 |
BioGRID (3 interactions; top human partners by supporting records): APP (Reconstituted Complex), DVL2 (Affinity Capture-MS), POLI (Reconstituted Complex)
Disease & clinical
Genetic variants
Variant evidence for ACTL7B: 99 ClinVar records (0 pathogenic / likely pathogenic); 9 GWAS associations.
ClinVar
99 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 92 |
| Likely benign | 5 |
| Benign | 2 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 10 predictions of 24):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 9:108855361 | donor_gain | 0.4900 | |
| 9:108855050 | donor_gain | 0.4600 | |
| 9:108855008 | donor_gain | 0.3800 | |
| 9:108854856 | donor_gain | 0.3400 | |
| 9:108855019 | acceptor_gain | 0.3400 | |
| 9:108855073 | donor_gain | 0.3200 | |
| 9:108855400 | donor_gain | 0.3100 | |
| 9:108855019 | acceptor_gain | 0.3000 | |
| 9:108855212 | donor_gain | 0.2900 | |
| 9:108855004 | donor_gain | 0.2800 |
AlphaMissense
604 missense substitutions predicted likely pathogenic (of 2,712 scored), across 193 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| F303 | 8 | 0.940 | 0.981 |
| D55 | 8 | 0.928 | 0.950 |
| F393 | 8 | 0.897 | 0.988 |
| F351 | 8 | 0.855 | 0.981 |
| W381 | 7 | 0.984 | 0.996 |
| F168 | 7 | 0.933 | 0.964 |
| W123 | 7 | 0.909 | 0.974 |
| R376 | 7 | 0.893 | 0.973 |
| W397 | 7 | 0.875 | 0.974 |
| F296 | 7 | 0.813 | 0.962 |
| F403 | 7 | 0.812 | 0.960 |
| K256 | 6 | 0.960 | 0.997 |
| K62 | 6 | 0.951 | 0.990 |
| G383 | 6 | 0.923 | 0.988 |
| G200 | 6 | 0.918 | 0.972 |
| G343 | 6 | 0.915 | 0.982 |
| G57 | 6 | 0.914 | 0.970 |
| G64 | 6 | 0.908 | 0.975 |
| P71 | 6 | 0.906 | 0.979 |
| G226 | 6 | 0.877 | 0.962 |
HPA cancer prognostics
RNA cancer specificity: Not detected
Disease associations
OMIM: gene MIM:604304 | disease phenotypes:
GWAS associations
9 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST010866_133 | Coronary artery disease | 1e-13 |
| GCST006979_862 | Heel bone mineral density | 4e-12 |
| GCST90013442_12 | Keratoconus | 3e-11 |
| GCST006979_219 | Heel bone mineral density | 2e-9 |
| GCST90000654_12 | Central corneal thickness | 2e-9 |
| GCST006979_220 | Heel bone mineral density | 3e-9 |
| GCST002652_8 | Cotinine glucuronidation | 2e-8 |
| GCST002074_6 | Paclitaxel-induced neuropathy | 6e-6 |
| GCST009391_550 | Metabolite levels | 7e-6 |
EFO canonical traits (from GWAS)
4 canonical traits:
| EFO ID | Trait name |
|---|---|
| EFO:0006508 | cotinine glucuronidation measurement |
| EFO:0009270 | heel bone mineral density |
| EFO:0010117 | pyruvate measurement |
| EFO:0005213 | central corneal thickness |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases methylation | 2 |
| aristolochic acid I | increases expression | 1 |
| bisphenol A | decreases expression | 1 |
| 2,4,5,2’,4’,5’-hexachlorobiphenyl | decreases expression | 1 |
| 3,4,5,3’,4’-pentachlorobiphenyl | decreases expression | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | increases abundance, decreases expression | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
| Permethrin | increases expression | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): keratoconus